Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study

Atherosclerosis

Volumn 243, Issue 2, 2015, Pages 560-566

  Cheng, Jin M ^a,b,c   Suoniemi, Matti ^d   Kardys, Isabella ^a,b   Vihervaara, Terhi ^d   de Boer, Sanneke P M ^a,b   Akkerhuis, K Martijn ^a,b   Sysi Aho, Marko ^d   Ekroos, Kim ^d   Garcia Garcia, Hector M ^e   Oemrawsingh, Rohit M ^a,b   Regar, Evelyn ^a,b   Koenig, Wolfgang ^f   Serruys, Patrick W ^a,e,g   van Geuns, Robert Jan ^a,b   Boersma, Eric ^a,b   Laaksonen, Reijo ^d,h,i  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d Zora Biosciences   (Finland)

^e CARDIALYSIS   (Netherlands)

^f UNIVERSITY HOSPITAL ULM   (Germany)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h TAMPERE UNIVERSITY HOSPITAL   (Finland)

ⁱ TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Atherosclerosis; Intravascular ultrasound; Lipids; Near infrared spectroscopy; Prognosis

Indexed keywords

CERAMIDE; CHOLESTEROL ESTER; LACTOSYLCERAMIDE; LIPID; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; INTRAVASCULAR ULTRASOUND CATHETER; INTRAVASCULAR ULTRASOUND SYSTEM; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEAR INFRARED IMAGING SYSTEM; NEAR INFRARED SPECTROSCOPY; PRIORITY JOURNAL; TISSUE NECROSIS; AGED; ATHEROSCLEROTIC PLAQUE; BLOOD; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; DISEASE COURSE; ECHOGRAPHY; INTERVENTIONAL ULTRASONOGRAPHY; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; NECROSIS; NETHERLANDS; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; RUPTURE;

ACUTE CORONARY SYNDROME; AGED; BIOMARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIPIDS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; NECROSIS; NETHERLANDS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; RUPTURE, SPONTANEOUS; SPECTROSCOPY, NEAR-INFRARED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84945577522     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.10.022     Document Type: Article

References (27)

1. Quehenberger O., Dennis E.A. The human plasma lipidome. New Engl. J. Med. 2011, 365:1812-1823.
2. Meikle P.J., Wong G., Tsorotes D., Barlow C.K., Weir J.M., Christopher M.J., MacIntosh G.L., Goudey B., Stern L., Kowalczyk A., Haviv I., White A.J., Dart A.M., Duffy S.J., Jennings G.L., Kingwell B.A. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2723-2732.
3. Stegemann C., Drozdov I., Shalhoub J., Humphries J., Ladroue C., Didangelos A., Baumert M., Allen M., Davies A.H., Monaco C., Smith A., Xu Q., Mayr M. Comparative lipidomics profiling of human atherosclerotic plaques. Circ. Cardiovasc. Genet. 2011, 4:232-242.
4. Stubiger G., Aldover-Macasaet E., Bicker W., Sobal G., Willfort-Ehringer A., Pock K., Bochkov V., Widhalm K., Belgacem O. Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using maldi-qit-tof-ms/ms. Atherosclerosis 2012, 224:177-186.
5. Tarasov K., Ekroos K., Suoniemi M., Kauhanen D., Sylvanne T., Hurme R., Gouni-Berthold I., Berthold H.K., Kleber M.E., Laaksonen R., Marz W. Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and pcsk9 deficiency. J. Clin. Endocrinol. Metab. 2014, 99:E45-E52.
6. Nair A., Margolis M.P., Kuban B.D., Vince D.G. Automated coronary plaque characterisation with intravascular ultrasound backscatter: Ex vivo validation. EuroIntervention 2007, 3:113-120.
7. Cheng J.M., Garcia-Garcia H.M., de Boer S.P., Kardys I., Heo J.H., Akkerhuis K.M., Oemrawsingh R.M., van Domburg R.T., Ligthart J., Witberg K.T., Regar E., Serruys P.W., van Geuns R.J., Boersma E. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the atheroremo-ivus study. Eur. Heart J. 2014, 35:639-647.
8. Stone G.W., Maehara A., Lansky A.J., de Bruyne B., Cristea E., Mintz G.S., Mehran R., McPherson J., Farhat N., Marso S.P., Parise H., Templin B., White R., Zhang Z., Serruys P.W. A prospective natural-history study of coronary atherosclerosis. New Engl. J. Med. 2011, 364:226-235.
9. Calvert P.A., Obaid D.R., O'Sullivan M., Shapiro L.M., McNab D., Densem C.G., Schofield P.M., Braganza D., Clarke S.C., Ray K.K., West N.E., Bennett M.R. Association between ivus findings and adverse outcomes in patients with coronary artery disease: the viva (vh-ivus in vulnerable atherosclerosis) study. JACC Cardiovasc. Imaging 2011, 4:894-901.
10. Gardner C.M., Tan H., Hull E.L., Lisauskas J.B., Sum S.T., Meese T.M., Jiang C., Madden S.P., Caplan J.D., Burke A.P., Virmani R., Goldstein J., Muller J.E. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC. Cardiovasc. Imaging 2008, 1:638-648.
11. Oemrawsingh R.M., Cheng J.M., Garcia-Garcia H.M., Van Geuns R.J., De Boer S.P.M., Simsek C., Kardys I., Lenzen M.J., Van Domburg R.T., Regar E., Serruys P.W., Akkerhuis K.M., Boersma E. Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease. J. Am. Coll. Cardiol. 2014, 64:2510-2518.
12. De Boer S.P., Cheng J.M., Garcia-Garcia H.M., Oemrawsingh R.M., van Geuns R.J., Regar E., Zijlstra F., Laaksonen R., Halperin E., Kleber M.E., Koenig W., Boersma E., Serruys P.W. Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the atheroremo-ivus study. EuroIntervention. 2013, 10.4244/EIJY13M08_01.
13. Ekroos K., Chernushevich I.V., Simons K., Shevchenko A. Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer. Anal. Chem. 2002, 74:941-949.
14. Merrill A.H., Sullards M.C., Allegood J.C., Kelly S., Wang E. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 2005, 36:207-224.
15. Stahlman M., Ejsing C.S., Tarasov K., Perman J., Boren J., Ekroos K. High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2009, 877:2664-2672.
16. Ejsing C.S., Duchoslav E., Sampaio J., Simons K., Bonner R., Thiele C., Ekroos K., Shevchenko A. Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal. Chem. 2006, 78:6202-6214.
17. Jung H.R., Sylvanne T., Koistinen K.M., Tarasov K., Kauhanen D., Ekroos K. High throughput quantitative molecular lipidomics. Biochim. Biophys. Acta 2011, 1811:925-934.
18. Garcia-Garcia H.M., Costa M.A., Serruys P.W. Imaging of coronary atherosclerosis: intravascular ultrasound. Eur. Heart J. 2010, 31:2456-2469.
19. Brugaletta S., Garcia-Garcia H.M., Serruys P.W., Gomez-Lara J., de Boer S., Ligthart J., Witberg K., Simsek C., van Geuns R.J., Schultz C., Duckers H.J., van Mieghem N., de Jaegere P., Madden S.P., Muller J.E., van der Steen A.F., Boersma E., van der Giessen W.J., Zijlstra F., Regar E. Distance of lipid core-rich plaques from the ostium by nirs in nonculprit coronary arteries. JACC Cardiovasc. Imaging 2012, 5:297-299.
20. Bismuth J., Lin P., Yao Q., Chen C. Ceramide: a common pathway for atherosclerosis?. Atherosclerosis 2008, 196:497-504.
21. Chatterjee S.B., Dey S., Shi W.Y., Thomas K., Hutchins G.M. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. Glycobiology 1997, 7:57-65.
22. Garner B., Mellor H.R., Butters T.D., Dwek R.A., Platt F.M. Modulation of thp-1 macrophage and cholesterol-loaded foam cell apolipoprotein e levels by glycosphingolipids. Biochem. Biophys. Res. Commun. 2002, 290:1361-1367.
23. Bietrix F., Lombardo E., van Roomen C.P., Ottenhoff R., Vos M., Rensen P.C., Verhoeven A.J., Aerts J.M., Groen A.K. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in apoe*3 leiden and low-density lipoprotein receptor-/- mice. Arterioscler. Thromb. Vasc. Biol. 2010, 30:931-937.
24. Billich A., Baumruker T. Sphingolipid metabolizing enzymes as novel therapeutic targets. Subcell. Biochem. 2008, 49:487-522.
25. Hojjati M.R., Li Z., Zhou H., Tang S., Huan C., Ooi E., Lu S., Jiang X.C. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoe-deficient mice. J. Biol. Chem. 2005, 280:10284-10289.
26. Nicholls S.J., Tuzcu E.M., Crowe T., Sipahi I., Schoenhagen P., Kapadia S., Hazen S.L., Wun C.C., Norton M., Ntanios F., Nissen S.E. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J. Am. Coll. Cardiol. 2006, 47:1967-1975.
27. Raber L., Taniwaki M., Zaugg S., Kelbaek H., Roffi M., Holmvang L., Noble S., Pedrazzini G., Moschovitis A., Luscher T.F., Matter C.M., Serruys P.W., Juni P., Garcia-Garcia H.M., Windecker S. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (ibis-4): a serial intravascular ultrasonography study. Eur. Heart J. 2015, 36:490-500.